Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. junior Avg
|
|
New words:
abrocitinib, accrual, amenable, anticalin, Appellate, Arrowhead, Asana, ASC, ASH, bermekimab, BIOCAD, biopolymer, Bipartisan, bluebird, Blueprint, captured, certiorari, CFDA, Chemistry, chemotherapy, Chengdu, Chinese, CHMP, Chugai, Codification, column, comment, compulsory, conbercept, concept, Congo, Congressional, constrained, construed, contemporaneously, copyright, CRSwNP, curative, Democratic, destroy, diffuse, dispensed, DLBCL, DoD, domain, dostarlimab, estoppel, etiokimab, extracting, faricimab, Fasenra, feedback, fevipiprant, filgotinib, FPC, Garetosmab, Glenmark, Hakko, HRSA, Incyte, inpatient, input, intentionally, introduce, introduced, investigationally, IOI, IPHC, JSC, Kanghong, Kiniksa, Kirin, Kodiak, Kyowa, laid, lebrikizumab, Libatyo, Libtayo, LuciNex, MA, Millennium, Munich, Mycenax, NASH, native, nemolizumab, neuromuscular, nonalcoholic, oncostatin, Ono, outbreak, ovarian, overcharge, owed, PanOptica, PAS, peficitinib, pharmacist, pilot, PMDA, pneumonia, Pozelimab, prepayment, prolonged, pronounced, proof, prostaglandin, PTAB, radiation, ranibizumab, recalculation, referral, REGENXBIO, relapsed, Republic, RNA, rulemaking, run, rural, software, spartalizumab, statutorily, supervision, suspension, tailored, Takeda, Terifay, tezepelumab, therefrom, tislelizumab, transparency, turnover, unsatisfied, upfront, urinary, usability, variant, vicinity, whichever, writ, XBiotech, Xolair
Removed:
Ablynx, abnormality, activation, AD, adjunct, Alder, allocate, alpha, alternate, applying, arthralgia, assignee, Australia, bad, baker, bargaining, binding, Breakthrough, buffer, capitalization, Cayman, cellular, CHD, children, cholesterol, circulating, closed, cognate, collective, colorectal, confirmation, contemplated, cooling, cytokine, decoy, deficit, deliverable, demyelination, deploy, digit, disruptive, dosage, efficient, Eleventh, emerge, ensuing, enzyme, EoE, existed, extracellular, Fargo, Fc, Fifteenth, FOLFIRI, formation, Fourteenth, fulfillment, fused, gemcitabine, Goldman, gout, hierarchy, IDMC, IgE, immunogenicity, Immunoglobulin, inadequately, incidence, indenture, inherited, inhibition, initiating, Inspector, insure, Intermittent, intolerant, intranasal, investee, investigated, irinotecan, landmark, leucovorin, LIBERTY, lipoprotein, literature, loading, Loan, Master, maximally, mCRC, modifying, modulating, morbidity, Morgan, mortality, Mt, Neil, nerve, neurocognitive, OIG, pancreatic, persistent, perspective, persuasive, placental, plasma, PlGF, post, principle, progressed, prospectively, purified, QUEST, RA, recommendation, recurrent, refund, regulating, rendered, resistant, responded, science, securing, separation, Seventeenth, showed, signaling, Sixteenth, soluble, solution, Stahl, standalone, Stanley, stimuli, subunit, Suisse, supplemented, swallowing, Syncytial, Thirteenth, tissue, top, track, Trustee, Twelfth, unamortized, uncontrolled, unknown, unprofitable, uptake, uric, visual, voted, Web, weekly, withheld, withholding
Filing tables
Filing exhibits
- 10-K Annual report
- 10.2.17 Stock Option Agreement (NQ) - Executive Officers
- 10.2.18 Stock Option Agreement (NQ) - P. Roy Vagelos
- 10.2.19 Restricted Stock Agreement - Executive Officers
- 10.2.20 Stock Option Agreement (NQ) - Non-employee Directors
- 10.2.21 Restricted Stock Unit Agreement - Non-employee Directors
- 10.17 Amended and Restated Immuno-oncology Discovery and Development Agreement
- 21.1 Subsidiaries of Regeneron Pharmaceuticals, Inc.
- 23.1 Consent of Pricewaterhousecoopers LLP
- 31.1 Certification of CEO Pursuant to Rule 13A-14(A)
- 31.2 Certification of CFO Pursuant to Rule 13A-14(A)
- 32 Certification of CEO and CFO Pursuant to 18 U.s.c. Section 1350
- Download Excel data file
- View Excel data file
Related press release
Associated REGN transcripts
REGN similar filings
Filing view
External links